Cardiovascular risk factors: A follow up study in a non-diabetic population

被引:1
|
作者
Vernet Vernet, Maria [1 ]
Sender Palacios, Maria Jose [1 ]
Jovell Fernandez, Esther [2 ]
Tor Figueras, Encarnacio [1 ]
Casals Riera, Ramon [1 ]
Larrosa Saez, Pere [1 ]
机构
[1] Consorci Sanitari Terrassa, CAP Terrassa Nord, Barcelona, Spain
[2] Consorci Sanitari Terrassa, Serv Epidemiol, Barcelona, Spain
来源
ATENCION PRIMARIA | 2010年 / 42卷 / 01期
关键词
Insulin resistance; Pancreatic beta-cell function; Cardiovascular risk factors; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; PREVALENCE; INTERHEART; MORTALITY; OBESITY; SPAIN; MODEL;
D O I
10.1016/j.aprim.2009.03.016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: To evaluate the cardiovascular risk factors (CVRF), their relationship with insulin resistance (IR) and pancreatic beta-cell (PBC) function in a known non-diabetic population, and to follow its progress over a period of 5 years. Design: Nested case-control study developed in two phases: the identification and characterisation of the cohort to study and the follow up. Setting: Urban Primary Care Centre. Participants: A non-diabetic population sample from 40 to 70 years. Main measurements: History of CVRF, physical examination (body mass index, abdominal girth, blood pressure), laboratory tests (fasting glucose, lipid profile and fasting insulin) and calculation of IR and PBC using the Homeostasis Model Assessment mathematical program. Results: Identification phase: 326 subjects. CVRF 32.5% dyslipaemia, 28.8% smoking, 28.2% obesity and 24.8% increased blood pressure. Number of CVRF: 37.7% had one, 21.5% two, 10.1% three and 2.1% four. Relationship between number of CVRF and IR. More IR in hypertensive, obese and dyslipaemic subjects. Follow up phase (5 years): 121 subjects. Significant proportion of dyslipaemia and impaired fasting glucose (IFG). Conclusions: The most common CVRF were dyslipaemia, smoking, obesity and raised blood pressure, with more IR in patients with high blood pressure, dyslipaemia and obesity and a higher number of CVRF in comparison with the rest of the population. At five years of follow up, an increase was only observed in the number of dyslipaemia and IFG and no reduction was achieved in the percentage of active smokers. (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [21] A comparative study of risk factors for corneal infection in diabetic and non-diabetic patients
    Wang, Bin
    Yang, Shuo
    Zhai, Hua-Lei
    Zhang, Yang-Yang
    Cui, Chun-Xia
    Wang, Jun-Yi
    Xie, Li-Xin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (01) : 43 - 47
  • [22] Non-diabetic glycosuria - A follow-up study with glucose tolerance tests
    Dewees, EJ
    Langner, PH
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1942, 204 (04): : 491 - 495
  • [23] CARDIOVASCULAR EVENTS AND INCEPTION OF DIALYSIS IN DIABETIC AND NON-DIABETIC CKD PATIENTS WITH CORONARY ARTERY CALCIFICATION. FOLLOW-UP STUDY
    Buonanno, Elisa
    Brancaccio, Stefania
    Fimiani, Vanessa
    Napolitano, Paola
    Spadola, Rosanna
    Morrone, Luigi
    Di Iorio, Biagio
    Russo, Domenico
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 379 - 379
  • [24] Adolescent Cardiovascular Risk Factors: A Follow-up Study
    Kilty, Heather Lee
    Prentice, Dawn
    CLINICAL NURSING RESEARCH, 2010, 19 (01) : 6 - 20
  • [25] FOLLOW-UP-STUDY ON PATIENTS WITH NON-ALCOHOLIC AND NON-DIABETIC FATTY LIVER
    MASSARRAT, S
    JORDAN, G
    SAHRHAGE, G
    ASHOLT, K
    SCHMITZMOORMANN, P
    BODE, JC
    ACTA HEPATO-GASTROENTEROLOGICA, 1979, 26 (04): : 296 - 301
  • [26] Mortality and educational level among diabetic and non-diabetic population in the Turin Longitudinal Study: a 9-year follow-up
    Gnavi, R
    Petrelli, A
    Demaria, M
    Spadea, T
    Carta, Q
    Costa, G
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2004, 33 (04) : 864 - 871
  • [27] Modifiable cardiovascular disease risk factors in the US diabetic and non-diabetic populations, 1994-2000
    Benjamin, SM
    Geiss, LS
    Greenlund, K
    Engelgau, MM
    DIABETES, 2002, 51 : A219 - A219
  • [28] Management of risk factors and use of cardiovascular drugs in diabetic and non-diabetic patients with coronary heart disease. EUROASPIRE Study
    Pyorala, K
    Lehto, S
    Wood, D
    DeBacquer, D
    DeBacker, G
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 314 - 314
  • [29] Risk factors for non-diabetic renal disease in diabetic patients
    Bermejo, Sheila
    Gonzalez, Ester
    Lopez-Revuelta, Katia
    Ibernon, Meritxell
    Lopez, Diana
    Martin-Gomez, Adoracion
    Garcia-Osuna, Rosa
    Linares, Tania
    Diaz, Montserrat
    Martin, Nadia
    Barros, Xoana
    Marco, Helena
    Isabel Navarro, Maruja
    Esparza, Noemi
    Elias, Sandra
    Coloma, Ana
    Roberto Robles, NicolaS
    Agraz, Irene
    Poch, Esteban
    Rodas, Lida
    Lozano, Victor
    Fernandez, Beatriz
    Hernandez, Eduardo
    Isabel Martinez, Maria
    Ionela Stanescu, Ramona
    Moiron, Jose Pelayo
    Garcia, Nuria
    Goicoechea, Marian
    Calero, Francesca
    Bonet, Josep
    Galceran, Josep M.
    Liano, Fernando
    Pascual, Julio
    Praga, Manuel
    Fulladosa, Xavier
    Jose Soler, Maria
    CLINICAL KIDNEY JOURNAL, 2020, 13 (03) : 380 - 388
  • [30] Association of hemoglobin glycation index with cardiovascular risk factors in non-diabetic adults: A cross-sectional study
    Rajendran, Suryapriya
    Mishra, Sasmita
    Madhavanpillai, Manju
    Vishnupriya, G.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (09)